Product
T cells (Tcon) and Regulatory T cells (Treg)
1 clinical trial
9 indications
Indication
Myeloid LeukemiaIndication
ChronicIndication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromesIndication
lymphomaIndication
Non-HodgkinIndication
Acute Lymphoblastic LeukemiaIndication
Myeloproliferative DisorderIndication
Chronic Myelogenous LeukemiaClinical trial
Phase 1-2 Trial for Patients With Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cellsStatus: Completed, Estimated PCD: 2023-12-20